Propofol's effects on nociceptive behavior and spinal C-fos expression afer intraplantar formalin injection in with a mutation in the gamma-aminobutyric acid-typeA β3 subunit

Austin W. Merrill, Linda S Barter, Uwe Rudolph, Edmond I. Eger, Joseph F. Antognini, Mirela Iodi Carstens, Earl Carstens

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

We investigated whether propofol affected nociceptive behavior and fos-like immunoreactivity (FLI) in the lumbo-sacral spinal cord after intraplantar formalin injection in wild-type (WT) mice and in mutant mice harboring a point mutation of the gamma-aminobutyric acid type A receptor, which renders them resistant to propofol. Bolus injection of propofol (30 mg/kg IV) in WT mice reduced phase 1 formalin-evoked behavior over the initial 2-3 min but did not alter phase 2 behavior or spinal FLI (64 ± 19 cells/section) compared with WT mice receiving intralipid vehicle plus intraplantar formalin (57 ± 19 cells/section). Most FLI was restricted to superficial dorsal horn laminae ipsilateral to the formalin injection. WT mice receiving a 60-min propofol infusion were anesthetized throughout and did not display nociceptive behavior but had FLI (58 ± 11 cells/section) that did not differ significantly from the other WT groups. Mutant mice receiving bolus injection of propofol (30 mg/kg) and intraplantar formalin were not anesthetized and exhibited nociceptive behavior. The total FLI in the spinal cord was 47 ± 29 cells/section. These data indicate that although propofol produces anesthesia, it does not prevent the FLI that is associated with nociception, a finding consistent with propofol lacking analgesic properties.

Original languageEnglish (US)
Pages (from-to)478-483
Number of pages6
JournalAnesthesia and Analgesia
Volume103
Issue number2
DOIs
StatePublished - Aug 2006

Fingerprint

Propofol
gamma-Aminobutyric Acid
Formaldehyde
Mutation
Injections
Spinal Cord
GABA Receptors
Nociception
Point Mutation
Analgesics
Anesthesia

ASJC Scopus subject areas

  • Anesthesiology and Pain Medicine

Cite this

Propofol's effects on nociceptive behavior and spinal C-fos expression afer intraplantar formalin injection in with a mutation in the gamma-aminobutyric acid-typeA β3 subunit. / Merrill, Austin W.; Barter, Linda S; Rudolph, Uwe; Eger, Edmond I.; Antognini, Joseph F.; Carstens, Mirela Iodi; Carstens, Earl.

In: Anesthesia and Analgesia, Vol. 103, No. 2, 08.2006, p. 478-483.

Research output: Contribution to journalArticle

Merrill, Austin W. ; Barter, Linda S ; Rudolph, Uwe ; Eger, Edmond I. ; Antognini, Joseph F. ; Carstens, Mirela Iodi ; Carstens, Earl. / Propofol's effects on nociceptive behavior and spinal C-fos expression afer intraplantar formalin injection in with a mutation in the gamma-aminobutyric acid-typeA β3 subunit. In: Anesthesia and Analgesia. 2006 ; Vol. 103, No. 2. pp. 478-483.
@article{b24ac3b710c4428d8439e552f5e4a9c4,
title = "Propofol's effects on nociceptive behavior and spinal C-fos expression afer intraplantar formalin injection in with a mutation in the gamma-aminobutyric acid-typeA β3 subunit",
abstract = "We investigated whether propofol affected nociceptive behavior and fos-like immunoreactivity (FLI) in the lumbo-sacral spinal cord after intraplantar formalin injection in wild-type (WT) mice and in mutant mice harboring a point mutation of the gamma-aminobutyric acid type A receptor, which renders them resistant to propofol. Bolus injection of propofol (30 mg/kg IV) in WT mice reduced phase 1 formalin-evoked behavior over the initial 2-3 min but did not alter phase 2 behavior or spinal FLI (64 ± 19 cells/section) compared with WT mice receiving intralipid vehicle plus intraplantar formalin (57 ± 19 cells/section). Most FLI was restricted to superficial dorsal horn laminae ipsilateral to the formalin injection. WT mice receiving a 60-min propofol infusion were anesthetized throughout and did not display nociceptive behavior but had FLI (58 ± 11 cells/section) that did not differ significantly from the other WT groups. Mutant mice receiving bolus injection of propofol (30 mg/kg) and intraplantar formalin were not anesthetized and exhibited nociceptive behavior. The total FLI in the spinal cord was 47 ± 29 cells/section. These data indicate that although propofol produces anesthesia, it does not prevent the FLI that is associated with nociception, a finding consistent with propofol lacking analgesic properties.",
author = "Merrill, {Austin W.} and Barter, {Linda S} and Uwe Rudolph and Eger, {Edmond I.} and Antognini, {Joseph F.} and Carstens, {Mirela Iodi} and Earl Carstens",
year = "2006",
month = "8",
doi = "10.1213/01.ane.0000223847.50233.1b",
language = "English (US)",
volume = "103",
pages = "478--483",
journal = "Anesthesia and Analgesia",
issn = "0003-2999",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Propofol's effects on nociceptive behavior and spinal C-fos expression afer intraplantar formalin injection in with a mutation in the gamma-aminobutyric acid-typeA β3 subunit

AU - Merrill, Austin W.

AU - Barter, Linda S

AU - Rudolph, Uwe

AU - Eger, Edmond I.

AU - Antognini, Joseph F.

AU - Carstens, Mirela Iodi

AU - Carstens, Earl

PY - 2006/8

Y1 - 2006/8

N2 - We investigated whether propofol affected nociceptive behavior and fos-like immunoreactivity (FLI) in the lumbo-sacral spinal cord after intraplantar formalin injection in wild-type (WT) mice and in mutant mice harboring a point mutation of the gamma-aminobutyric acid type A receptor, which renders them resistant to propofol. Bolus injection of propofol (30 mg/kg IV) in WT mice reduced phase 1 formalin-evoked behavior over the initial 2-3 min but did not alter phase 2 behavior or spinal FLI (64 ± 19 cells/section) compared with WT mice receiving intralipid vehicle plus intraplantar formalin (57 ± 19 cells/section). Most FLI was restricted to superficial dorsal horn laminae ipsilateral to the formalin injection. WT mice receiving a 60-min propofol infusion were anesthetized throughout and did not display nociceptive behavior but had FLI (58 ± 11 cells/section) that did not differ significantly from the other WT groups. Mutant mice receiving bolus injection of propofol (30 mg/kg) and intraplantar formalin were not anesthetized and exhibited nociceptive behavior. The total FLI in the spinal cord was 47 ± 29 cells/section. These data indicate that although propofol produces anesthesia, it does not prevent the FLI that is associated with nociception, a finding consistent with propofol lacking analgesic properties.

AB - We investigated whether propofol affected nociceptive behavior and fos-like immunoreactivity (FLI) in the lumbo-sacral spinal cord after intraplantar formalin injection in wild-type (WT) mice and in mutant mice harboring a point mutation of the gamma-aminobutyric acid type A receptor, which renders them resistant to propofol. Bolus injection of propofol (30 mg/kg IV) in WT mice reduced phase 1 formalin-evoked behavior over the initial 2-3 min but did not alter phase 2 behavior or spinal FLI (64 ± 19 cells/section) compared with WT mice receiving intralipid vehicle plus intraplantar formalin (57 ± 19 cells/section). Most FLI was restricted to superficial dorsal horn laminae ipsilateral to the formalin injection. WT mice receiving a 60-min propofol infusion were anesthetized throughout and did not display nociceptive behavior but had FLI (58 ± 11 cells/section) that did not differ significantly from the other WT groups. Mutant mice receiving bolus injection of propofol (30 mg/kg) and intraplantar formalin were not anesthetized and exhibited nociceptive behavior. The total FLI in the spinal cord was 47 ± 29 cells/section. These data indicate that although propofol produces anesthesia, it does not prevent the FLI that is associated with nociception, a finding consistent with propofol lacking analgesic properties.

UR - http://www.scopus.com/inward/record.url?scp=33746579134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33746579134&partnerID=8YFLogxK

U2 - 10.1213/01.ane.0000223847.50233.1b

DO - 10.1213/01.ane.0000223847.50233.1b

M3 - Article

C2 - 16861438

AN - SCOPUS:33746579134

VL - 103

SP - 478

EP - 483

JO - Anesthesia and Analgesia

JF - Anesthesia and Analgesia

SN - 0003-2999

IS - 2

ER -